Form 4: Zoetis Executive Julie Fuller Reports Stock and Option Awards

Executive Vice President Julie Fuller reports the acquisition of restricted stock units and stock options in Zoetis Inc.

Summary

• Julie Fuller, an Executive Vice President at Zoetis Inc., filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
• On February 19, 2025, Fuller was granted 2,218 restricted stock units (RSUs) and 8,642 stock options.
• These awards were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
• The RSUs will vest in three equal installments on the first, second, and third anniversaries of the grant date, contingent upon continued service.
• Each RSU represents the right to receive one share of Zoetis Inc. common stock.
• The stock options have an exercise price of $156.64 and also vest in three equal installments on the first, second, and third anniversaries of the grant date.
• The options expire ten years from the grant date.
• Fuller also directly owns 2,336.5685 restricted stock units that vest on September 30, 2024.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating a stable and incentivized management structure. The sentiment is neutral to slightly positive.

Positives

• The grant of RSUs and stock options aligns the executive's interests with those of the shareholders.
• Vesting schedules incentivize continued service and commitment to the company's long-term success.

Future Outlook

The vesting of the RSUs and stock options is contingent upon the reporting person's continued service.

Industry Context

Equity grants are a common practice in the pharmaceutical industry to incentivize and retain key executives.

Comparison to Industry Standards

• Stock option and RSU grants are standard components of executive compensation packages in publicly traded companies like Zoetis.
• Companies such as Eli Lilly and Company and Merck & Co. also utilize similar equity-based compensation plans to align executive incentives with shareholder value.

Stakeholder Impact

• The equity grants align management's interests with those of shareholders, potentially driving long-term value creation.

Key Dates

Keywords

Zoetis, Form 4, Stock Options, Restricted Stock Units, Executive Compensation, Beneficial Ownership, Equity Incentive Plan